{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:48:43Z","timestamp":1785743323156,"version":"3.56.0"},"reference-count":72,"publisher":"Probiologists Limited","issue":"1","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.probiologists.com\/policies"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Breast Cancer Res"],"abstract":"<jats:p>Background\/Objectives: Triple-negative breast cancer (TNBC) disproportionately affects African American (AA) women, yet the molecular mechanisms remain poorly understood. Emerging evidence suggests that microRNAs (miRNAs) may play a critical role in cancer progression. This study investigated the association of HTR2A genetic variants and miRNA dysregulation in AA women with breast cancer.\n\nMethods: A total of 417 AA women (192 with breast cancer, 225 controls) were genotyped for selected HTR2A SNPs. Functional predictions and molecular modeling assessed structural impact. TNBC cell lines were treated with an HTR2A agonist, and miRNA expression was profiled using the NanoString, and bioinformatic tools were applied to identify miRNA targets and associated oncogenic pathways. \n\nResults: Three SNPs (rs6304, rs6311, and rs1745837) were significantly associated with breast cancer risk (e.g., rs6311 dominant model: OR = 11.98, 95% CI: 6.63\u201321.66, p &lt; 0.0001). The rs6304 demonstrated predicted protein destabilization. Six oncogenic miRNAs (including miR-92a-3p and miR-377-3p) were significantly upregulated (p &lt; 0.05) and involved in PI3K\/AKT, JAK\/STAT, and IL-6 pathways. \n\nConclusions: HTR2A genetic variation, miRNA dysregulation, and increased breast cancer risk in AA women. These findings suggest that HTR2A variants and miRNA profiles may serve as potential biomarkers for risk stratification and targeted therapeutic approaches in TNBC.\n\nSimple Summary: African American women face a higher risk of developing a particularly aggressive type of breast cancer called TNBC. This study explores how changes in a specific serotonin receptor gene, known as HTR2A, might contribute to this risk. By analyzing the DNA of AA women and conducting lab experiments, the researchers identified genetic variations that are more common in women with breast cancer. They also discovered that these genetic changes may affect the way small molecules called microRNAs control cell growth. Understanding these links may help scientists find better ways to detect and treat breast cancer in AA women, paving the way for more personalized and effective medical care.<\/jats:p>","DOI":"10.46439\/breastcancer.6.037","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:34:35Z","timestamp":1785742475000},"page":"65","source":"Crossref","is-referenced-by-count":0,"title":["Uncovering genetic variations in HTR2A and miRNAs drivers of breast cancer risk in African American women"],"prefix":"10.46439","volume":"6","author":[{"given":"Nicole","family":"Retland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl M.","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph I.","family":"Aubee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Apprey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somiranjan","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Copeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmine","family":"Kanaan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yayin","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Ramadan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Brim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muneer M.","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"25620","published-online":{"date-parts":[[2026,8,1]]},"reference":[{"key":"ref0","doi-asserted-by":"crossref","unstructured":"1. De Deurwaerd\u00e8re P, Di Giovanni G. Serotonin in Health and Disease. Int J Mol Sci. 2020 May 15;21(10):3500.","DOI":"10.3390\/ijms21103500"},{"key":"ref1","doi-asserted-by":"crossref","unstructured":"2. Rapport MM, Green AA, Page IH. Partial purification of the vasoconstrictor in beef serum. J Biol Chem. 1948 Jun;174(2):735\u201341.","DOI":"10.1016\/S0021-9258(18)57355-5"},{"key":"ref2","doi-asserted-by":"crossref","unstructured":"3. Stiedl O, Pappa E, Konradsson-Geuken \u00c5, \u00d6gren SO. The role of the serotonin receptor subtypes 5-HT1A and 5-HT7 and its interaction in emotional learning and memory. Front Pharmacol. 2015 Aug 7;6:162.","DOI":"10.3389\/fphar.2015.00162"},{"key":"ref3","doi-asserted-by":"crossref","unstructured":"4. Berger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355\u201366.","DOI":"10.1146\/annurev.med.60.042307.110802"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"5. Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. CA Cancer J Clin. 2025 Jan-Feb;75(1):10\u201345.","DOI":"10.3322\/caac.21871"},{"key":"ref5","doi-asserted-by":"crossref","unstructured":"6. Hernandez LL, Gregerson KA, Horseman ND. Mammary gland serotonin regulates parathyroid hormone-related protein and other bone-related signals. Am J Physiol Endocrinol Metab. 2012 Apr 15;302(8):E1009\u201315.","DOI":"10.1152\/ajpendo.00666.2011"},{"key":"ref6","doi-asserted-by":"crossref","unstructured":"7. Lund ML, Egerod KL, Engelstoft MS, Dmytriyeva O, Theodorsson E, Patel BA, et al. Enterochromaffin 5-HT cells - A major target for GLP-1 and gut microbial metabolites. Mol Metab. 2018 May;11:70\u201383.","DOI":"10.1016\/j.molmet.2018.03.004"},{"key":"ref7","doi-asserted-by":"crossref","unstructured":"8. O'Mahony SM, Clarke G, Borre YE, Dinan TG, Cryan JF. Serotonin, tryptophan metabolism and the brain-gut-microbiome axis. Behav Brain Res. 2015 Jan 15;277:32\u201348.","DOI":"10.1016\/j.bbr.2014.07.027"},{"key":"ref8","doi-asserted-by":"crossref","unstructured":"9. Banskota S, Khan WI. Gut-derived serotonin and its emerging roles in immune function, inflammation, metabolism and the gut-brain axis. Curr Opin Endocrinol Diabetes Obes. 2022 Apr 1;29(2):177\u2013182.","DOI":"10.1097\/MED.0000000000000713"},{"key":"ref9","doi-asserted-by":"crossref","unstructured":"10. Walther DJ, Peter JU, Bashammakh S, H\u00f6rtnagl H, Voits M, Fink H, et al. Synthesis of serotonin by a second tryptophan hydroxylase isoform. Science. 2003 Jan 3;299(5603):76.","DOI":"10.1126\/science.1078197"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"11. Namkung J, Kim H, Park S. Peripheral Serotonin: a New Player in Systemic Energy Homeostasis. Mol Cells. 2015 Dec;38(12):1023\u20138.","DOI":"10.14348\/molcells.2015.0258"},{"key":"ref11","doi-asserted-by":"crossref","unstructured":"12. McCorvy JD, Roth BL. Structure and function of serotonin G protein-coupled receptors. Pharmacol Ther. 2015 Jun;150:129\u201342.","DOI":"10.1016\/j.pharmthera.2015.01.009"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"13. erger M, Gray JA, Roth BL. The expanded biology of serotonin. Annu Rev Med. 2009;60:355\u201366.","DOI":"10.1146\/annurev.med.60.042307.110802"},{"key":"ref13","doi-asserted-by":"crossref","unstructured":"14. Matthes S, Bader M. Peripheral Serotonin Synthesis as a New Drug Target. Trends Pharmacol Sci. 2018 Jun;39(6):560\u201372.","DOI":"10.1016\/j.tips.2018.03.004"},{"key":"ref14","doi-asserted-by":"crossref","unstructured":"15. e Deurwaerd\u00e8re P, Di Giovanni G. Serotonin in Health and Disease. Int J Mol Sci. 2020 May 15;21(10):3500.","DOI":"10.3390\/ijms21103500"},{"key":"ref15","doi-asserted-by":"crossref","unstructured":"16. Karmakar S, Lal G. Role of serotonin receptor signaling in cancer cells and anti-tumor immunity. Theranostics. 2021 Mar 11;11(11):5296\u2013312.","DOI":"10.7150\/thno.55986"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"17. Balakrishna P, George S, Hatoum H, Mukherjee S. Serotonin Pathway in Cancer. Int J Mol Sci. 2021 Jan 28;22(3):1268.","DOI":"10.3390\/ijms22031268"},{"key":"ref17","doi-asserted-by":"crossref","unstructured":"18. Sarrouilhe D, Clarhaut J, Defamie N, Mesnil M. Serotonin and cancer: what is the link? Curr Mol Med. 2015;15(1):62\u201377.","DOI":"10.2174\/1566524015666150114113411"},{"key":"ref18","doi-asserted-by":"crossref","unstructured":"19. Hejazi SH, Ahangari G, Pornour M, Deezagi A, Aminzadeh S, Ahmadkhaniha HR, et al. Evaluation of gene expression changes of serotonin receptors, 5-HT3AR and 5-HT2AR as main stress factors in breast cancer patients. Asian Pac J Cancer Prev. 2014;15(11):4455\u20138.","DOI":"10.7314\/APJCP.2014.15.11.4455"},{"key":"ref19","doi-asserted-by":"crossref","unstructured":"20. Hejazi SH, Ahangari G, Deezagi A. Alternative Viewpoint Against Breast Cancer Based on Selective Serotonin Receptors 5HTR3A and 5HTR2A Antagonists that can Mediate Apoptosis in MCF-7 Cell Line. Curr Drug Discov Technol. 2015;12(4):240\u20139.","DOI":"10.2174\/1570163813666151126215210"},{"key":"ref20","doi-asserted-by":"crossref","unstructured":"21. Sonier B, Arseneault M, Lavigne C, Ouellette RJ, Vaillancourt C. The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun. 2006 May 19;343(4):1053\u20139.","DOI":"10.1016\/j.bbrc.2006.03.080"},{"key":"ref21","doi-asserted-by":"crossref","unstructured":"22. Leoncikas V, Wu H, Ward LT, Kierzek AM, Plant NJ. Generation of 2,000 breast cancer metabolic landscapes reveals a poor prognosis group with active serotonin production. Sci Rep. 2016 Jan 27;6:19771.","DOI":"10.1038\/srep19771"},{"key":"ref22","unstructured":"23. Hurvitz S, Mead M. Triple-negative breast cancer: advancements in characterization and treatment approach. Curr Opin Obstet Gynecol. 2016 Feb;28(1):59\u201369."},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"24. Davis MB, Newman LA. Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes? Surg Oncol Clin N Am. 2018 Jan;27(1):217\u201334.","DOI":"10.1016\/j.soc.2017.07.009"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"25. He Y, Liu H, Chen Q, Shao Y, Luo S. Relationships between SNPs and prognosis of breast cancer and pathogenic mechanism. Mol Genet Genomic Med. 2019 Sep;7(9):e871.","DOI":"10.1002\/mgg3.871"},{"key":"ref25","doi-asserted-by":"crossref","unstructured":"26. Sachidanandam R, Weissman D, Schmidt SC, Kakol JM, Stein LD, Marth G, et al; International SNP Map Working Group. A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms. Nature. 2001 Feb 15;409(6822):928\u201333.","DOI":"10.1038\/35057149"},{"key":"ref26","doi-asserted-by":"crossref","unstructured":"27. Hindorff LA, Sethupathy P, Junkins HA, Ramos EM, Mehta JP, Collins FS, et al. Potential etiologic and functional implications of genome-wide association loci for human diseases and traits. Proc Natl Acad Sci U S A. 2009 Jun 9;106(23):9362\u20137.","DOI":"10.1073\/pnas.0903103106"},{"key":"ref27","doi-asserted-by":"crossref","unstructured":"28. McCarthy MI, Abecasis GR, Cardon LR, Goldstein DB, Little J, Ioannidis JP, et al. Genome-wide association studies for complex traits: consensus, uncertainty and challenges. Nat Rev Genet. 2008 May;9(5):356\u201369.","DOI":"10.1038\/nrg2344"},{"key":"ref28","doi-asserted-by":"crossref","unstructured":"29. Handy DE, Castro R, Loscalzo J. Epigenetic modifications: basic mechanisms and role in cardiovascular disease. Circulation. 2011 May 17;123(19):2145\u201356.","DOI":"10.1161\/CIRCULATIONAHA.110.956839"},{"key":"ref29","doi-asserted-by":"crossref","unstructured":"30. Wahid F, Shehzad A, Khan T, Kim YY. MicroRNAs: synthesis, mechanism, function, and recent clinical trials. Biochim Biophys Acta. 2010 Nov;1803(11):1231\u201343.","DOI":"10.1016\/j.bbamcr.2010.06.013"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"31. Ho PTB, Clark IM, Le LTT. MicroRNA-Based Diagnosis and Therapy. Int J Mol Sci. 2022 Jun 28;23(13):7167.","DOI":"10.3390\/ijms23137167"},{"key":"ref31","doi-asserted-by":"crossref","unstructured":"32. Saliminejad K, Khorram Khorshid HR, Soleymani Fard S, Ghaffari SH. An overview of microRNAs: Biology, functions, therapeutics, and analysis methods. J Cell Physiol. 2019 May;234(5):5451\u201365.","DOI":"10.1002\/jcp.27486"},{"key":"ref32","doi-asserted-by":"crossref","unstructured":"33. Paul P, Chakraborty A, Sarkar D, Langthasa M, Rahman M, Bari M, et al. Interplay between miRNAs and human diseases. J Cell Physiol. 2018 Mar;233(3):2007\u201318.","DOI":"10.1002\/jcp.25854"},{"key":"ref33","doi-asserted-by":"crossref","unstructured":"34. Hill M, Tran N. miRNA interplay: mechanisms and consequences in cancer. Dis Model Mech. 2021 Apr 1;14(4):dmm047662.","DOI":"10.1242\/dmm.047662"},{"key":"ref34","doi-asserted-by":"crossref","unstructured":"35. Rodrigues CH, Pires DE, Ascher DB. DynaMut: predicting the impact of mutations on protein conformation, flexibility and stability. Nucleic Acids Res. 2018 Jul 2;46(W1):W350\u2013W355.","DOI":"10.1093\/nar\/gky300"},{"key":"ref35","unstructured":"36. Sujitha SP, Nair A, Banerjee M, Lakshmanan S, Harshavaradhan S, Gunasekaran S, et al. 5-Hydroxytryptamine (serotonin) 2A receptor gene polymorphism is associated with schizophrenia. Indian J Med Res. 2014 Dec;140(6):736\u201343."},{"key":"ref36","doi-asserted-by":"crossref","unstructured":"37. Banlaki Z, Elek Z, Nanasi T, Szekely A, Nemoda Z, Sasvari-Szekely M, et al. Polymorphism in the serotonin receptor 2a (HTR2A) gene as possible predisposal factor for aggressive traits. PLoS One. 2015 Feb 6;10(2):e0117792.","DOI":"10.1371\/journal.pone.0117792"},{"key":"ref37","doi-asserted-by":"crossref","unstructured":"38. Harvey L, Reid RE, Ma C, Knight PJ, Pfeifer TA, Grigliatti TA. Human genetic variations in the 5HT2A receptor: a single nucleotide polymorphism identified with altered response to clozapine. Pharmacogenetics. 2003 Feb;13(2):107\u201318.","DOI":"10.1097\/00008571-200302000-00007"},{"key":"ref38","doi-asserted-by":"crossref","unstructured":"39. Meyerson M. Human genetic variation and disease. Lancet. 2003 Jul 26;362(9380):259\u201360.","DOI":"10.1016\/S0140-6736(03)14002-0"},{"key":"ref39","doi-asserted-by":"crossref","unstructured":"40. Duzkale H, Shen J, McLaughlin H, Alfares A, Kelly MA, Pugh TJ, et al. A systematic approach to assessing the clinical significance of genetic variants. Clin Genet. 2013 Nov;84(5):453\u201363.","DOI":"10.1111\/cge.12257"},{"key":"ref40","doi-asserted-by":"crossref","unstructured":"41. Kling A, Seddighzadeh M, Arlestig L, Alfredsson L, Rantap\u00e4\u00e4-Dahlqvist S, Padyukov L. Genetic variations in the serotonin 5-HT2A receptor gene (HTR2A) are associated with rheumatoid arthritis. Ann Rheum Dis. 2008 Aug;67(8):1111\u20135.","DOI":"10.1136\/ard.2007.074948"},{"key":"ref41","doi-asserted-by":"crossref","unstructured":"42. Korytina GF, Akhmadishina LZ, Kochetova OV, Aznabaeva YG, Zagidullin SZ, Victorova TV. [Polymorphic Variants of Glutamate Receptor (GRIK5, GRIN2B) and Serotonin Receptor (HTR2A) Genes Are Associated with Chronic Obstructive Pulmonary Disease]. Mol Biol (Mosk). 2017 Jul-Aug;51(4):603\u2013614. Russian.","DOI":"10.1134\/S0026893317040124"},{"key":"ref42","doi-asserted-by":"crossref","unstructured":"43. Choi JR, Jeon M, Koh SB. Association between serotonin 2A receptor (HTR2A) genetic variations and risk of hypertension in a community-based cohort study. BMC Med Genet. 2020 Jan 6;21(1):5.","DOI":"10.1186\/s12881-019-0927-3"},{"key":"ref43","doi-asserted-by":"crossref","unstructured":"44. Kircher M, Witten DM, Jain P, O'Roak BJ, Cooper GM, Shendure J. A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet. 2014 Mar;46(3):310\u20135.","DOI":"10.1038\/ng.2892"},{"key":"ref44","doi-asserted-by":"crossref","unstructured":"45. Madelaine R, Notwell JH, Skariah G, Halluin C, Chen CC, Bejerano G, et al. A screen for deeply conserved non-coding GWAS SNPs uncovers a MIR-9-2 functional mutation associated to retinal vasculature defects in human. Nucleic Acids Res. 2018 Apr 20;46(7):3517\u201331.","DOI":"10.1093\/nar\/gky166"},{"key":"ref45","doi-asserted-by":"crossref","unstructured":"46. Castle JC. SNPs occur in regions with less genomic sequence conservation. PLoS One. 2011;6(6):e20660.","DOI":"10.1371\/journal.pone.0020660"},{"key":"ref46","doi-asserted-by":"crossref","unstructured":"47. Nishi H, Tyagi M, Teng S, Shoemaker BA, Hashimoto K, Alexov E, et al. Cancer missense mutations alter binding properties of proteins and their interaction networks. PLoS One. 2013 Jun 14;8(6):e66273.","DOI":"10.1371\/journal.pone.0066273"},{"key":"ref47","doi-asserted-by":"crossref","unstructured":"48. Robert F, Pelletier J. Exploring the Impact of Single-Nucleotide Polymorphisms on Translation. Front Genet. 2018 Oct 30;9:507.","DOI":"10.3389\/fgene.2018.00507"},{"key":"ref48","doi-asserted-by":"crossref","unstructured":"49. Tokuriki N, Stricher F, Serrano L, Tawfik DS. How protein stability and new functions trade off. PLoS Comput Biol. 2008 Feb 29;4(2):e1000002.","DOI":"10.1371\/journal.pcbi.1000002"},{"key":"ref49","doi-asserted-by":"crossref","unstructured":"50. Thompson MD, Hendy GN, Percy ME, Bichet DG, Cole DE. G protein-coupled receptor mutations and human genetic disease. Methods Mol Biol. 2014;1175:153\u201387.","DOI":"10.1007\/978-1-4939-0956-8_8"},{"key":"ref50","doi-asserted-by":"crossref","unstructured":"51. Shan J, Weinstein H, Mehler EL. Probing the structural determinants for the function of intracellular loop 2 in structurally cognate G-protein-coupled receptors. Biochemistry. 2010 Dec 21;49(50):10691\u2013701.","DOI":"10.1021\/bi100580s"},{"key":"ref51","doi-asserted-by":"crossref","unstructured":"52. Davis MB, Newman LA. Breast Cancer Disparities: How Can We Leverage Genomics to Improve Outcomes? Surg Oncol Clin N Am. 2018 Jan;27(1):217\u201334.","DOI":"10.1016\/j.soc.2017.07.009"},{"key":"ref52","doi-asserted-by":"crossref","unstructured":"53. Myers RL, Airey DC, Manier DH, Shelton RC, Sanders-Bush E. Polymorphisms in the regulatory region of the human serotonin 5-HT2A receptor gene (HTR2A) influence gene expression. Biol Psychiatry. 2007 Jan 15;61(2):167\u201373.","DOI":"10.1016\/j.biopsych.2005.12.018"},{"key":"ref53","doi-asserted-by":"crossref","unstructured":"54. Bagheri F, Mesrian Tanha H, Mojtabavi Naeini M, Ghaedi K, Azadeh M. Tumor-promoting function of single nucleotide polymorphism rs1836724 (C3388T) alters multiple potential legitimate microRNA binding sites at the 3'-untranslated region of ErbB4 in breast cancer. Mol Med Rep. 2016 May;13(5):4494\u20138.","DOI":"10.3892\/mmr.2016.5078"},{"key":"ref54","doi-asserted-by":"crossref","unstructured":"55. Gwynne WD, Hallett RM, Girgis-Gabardo A, Bojovic B, Dvorkin-Gheva A, Aarts C, et al. Serotonergic system antagonists target breast tumor initiating cells and synergize with chemotherapy to shrink human breast tumor xenografts. Oncotarget. 2017 May 9;8(19):32101\u201316.","DOI":"10.18632\/oncotarget.16646"},{"key":"ref55","doi-asserted-by":"crossref","unstructured":"56. Soll C, Jang JH, Riener MO, Moritz W, Wild PJ, Graf R, et al. Serotonin promotes tumor growth in human hepatocellular cancer. Hepatology. 2010 Apr;51(4):1244\u201354.","DOI":"10.1002\/hep.23441"},{"key":"ref56","doi-asserted-by":"crossref","unstructured":"57. Zaminpira S, Zaminpira S, Niknamian S, Internationals O. The Impact of the Serotonin on the Cause and Treatment of Cancer. Int J Cancer Oncol. 2017;5: 1\u20137.","DOI":"10.15436\/2377-0902.17.1629"},{"key":"ref57","doi-asserted-by":"crossref","unstructured":"58. Pai VP, Marshall AM, Hernandez LL, Buckley AR, Horseman ND. Altered serotonin physiology in human breast cancers favors paradoxical growth and cell survival. Breast Cancer Res. 2009;11(6):R81.","DOI":"10.1186\/bcr2448"},{"key":"ref58","doi-asserted-by":"crossref","unstructured":"59. Sonier B, Arseneault M, Lavigne C, Ouellette RJ, Vaillancourt C. The 5-HT2A serotoninergic receptor is expressed in the MCF-7 human breast cancer cell line and reveals a mitogenic effect of serotonin. Biochem Biophys Res Commun. 2006 May 19;343(4):1053\u20139.","DOI":"10.1016\/j.bbrc.2006.03.080"},{"key":"ref59","doi-asserted-by":"crossref","unstructured":"60. Oufkir T, Vaillancourt C. Phosphorylation of JAK2 by serotonin 5-HT (2A) receptor activates both STAT3 and ERK1\/2 pathways and increases growth of JEG-3 human placental choriocarcinoma cell. Placenta. 2011 Dec;32(12):1033\u201340.","DOI":"10.1016\/j.placenta.2011.09.005"},{"key":"ref60","doi-asserted-by":"crossref","unstructured":"61. Oufkir T, Arseneault M, Sanderson JT, Vaillancourt C. The 5-HT 2A serotonin receptor enhances cell viability, affects cell cycle progression and activates MEK-ERK1\/2 and JAK2-STAT3 signalling pathways in human choriocarcinoma cell lines. Placenta. 2010 May;31(5):439\u201347.","DOI":"10.1016\/j.placenta.2010.02.019"},{"key":"ref61","doi-asserted-by":"crossref","unstructured":"62. Ying J, Li H, Cui Y, Wong AH, Langford C, Tao Q. Epigenetic disruption of two proapoptotic genes MAPK10\/JNK3 and PTPN13\/FAP-1 in multiple lymphomas and carcinomas through hypermethylation of a common bidirectional promoter. Leukemia. 2006 Jun;20(6):1173\u20135.","DOI":"10.1038\/sj.leu.2404193"},{"key":"ref62","doi-asserted-by":"crossref","unstructured":"63. Yi T, Zhou X, Sang K, Zhou J, Ge L. MicroRNA-1270 modulates papillary thyroid cancer cell development by regulating SCAI. Biomed Pharmacother. 2019 Jan;109:2357\u201364.","DOI":"10.1016\/j.biopha.2018.08.150"},{"key":"ref63","doi-asserted-by":"crossref","unstructured":"64. Almohaywi M, Sugita BM, Centa A, Fonseca AS, Antunes VC, Fadda P, et al. Deregulated miRNA Expression in Triple-Negative Breast Cancer of Ancestral Genomic-Characterized Latina Patients. Int J Mol Sci. 2023 Aug 22;24(17):13046.","DOI":"10.3390\/ijms241713046"},{"key":"ref64","doi-asserted-by":"crossref","unstructured":"65. Yang XH, Guo F. miR\u20113147 serves as an oncomiR in vulvar squamous cell cancer via Smad4 suppression. Mol Med Rep. 2018 May;17(5):6397\u2013404.","DOI":"10.3892\/mmr.2018.8697"},{"key":"ref65","doi-asserted-by":"crossref","unstructured":"66. Yang F, Luo LJ, Zhang L, Wang DD, Yang SJ, Ding L, et al. MiR-346 promotes the biological function of breast cancer cells by targeting SRCIN1 and reduces chemosensitivity to docetaxel. Gene. 2017 Feb 5;600:21\u20138.","DOI":"10.1016\/j.gene.2016.11.037"},{"key":"ref66","doi-asserted-by":"crossref","unstructured":"67. Wen X, Wu JQ, Peng W, Feng JF, Tang JH. MicroRNA-377 predicts poor clinical outcome of gastric cancer and induces tumorigenesis by targeting multiple tumor-suppressor genes. Oncol Rep. 2015 Jul;34(1):203\u201310.","DOI":"10.3892\/or.2015.3981"},{"key":"ref67","doi-asserted-by":"crossref","unstructured":"68. Cun J, Yang Q. Bioinformatics-based interaction analysis of miR-92a-3p and key genes in tamoxifen-resistant breast cancer cells. Biomed Pharmacother. 2018 Nov;107:117\u201328.","DOI":"10.1016\/j.biopha.2018.07.158"},{"key":"ref68","doi-asserted-by":"crossref","unstructured":"69. Carbognin L, Miglietta F, Paris I, Dieci MV. Prognostic and Predictive Implications of PTEN in Breast Cancer: Unfulfilled Promises but Intriguing Perspectives. Cancers (Basel). 2019 Sep 19;11(9):1401.","DOI":"10.3390\/cancers11091401"},{"key":"ref69","doi-asserted-by":"crossref","unstructured":"70. Ye J, Yao Y, Song Q, Li S, Hu Z, Yu Y, et al. Up-regulation of miR-95-3p in hepatocellular carcinoma promotes tumorigenesis by targeting p21 expression. Sci Rep. 2016 Oct 4;6:34034.","DOI":"10.1038\/srep34034"},{"key":"ref70","doi-asserted-by":"crossref","unstructured":"71. Khanabdali R, Zhu S, Moore M, Vincent E, Rice G. Abstract LB258: Automated high-throughput isolation of extracellular vesicles (EVs) and small RNA sequencing profile in serum of breast cancer patients. Cancer Res. 2025;85:LB258.","DOI":"10.1158\/1538-7445.AM2025-LB258"},{"key":"ref71","doi-asserted-by":"crossref","unstructured":"72. Younis OM, Yasin JA, Mansour A, Abdulla M, Alsafadi D, Ahram M. Abstract 7468: Androgen response and prognostication in luminal androgen receptor-positive TNBC patients: Defining a novel signature. Cancer Res. 2025;85:7468.","DOI":"10.1158\/1538-7445.AM2025-7468"}],"container-title":["Journal of Breast Cancer Research"],"original-title":[],"deposited":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T07:34:46Z","timestamp":1785742486000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.probiologists.com\/article\/uncovering-genetic-variations-in-htr2a-and-mirnas-drivers-of-breast-cancer-risk-in-african-american-women"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,1]]},"references-count":72,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,8,3]]}},"URL":"https:\/\/doi.org\/10.46439\/breastcancer.6.037","relation":{},"ISSN":["2769-2418"],"issn-type":[{"value":"2769-2418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,1]]}}}